血小板增多症
脾切除术
血小板
医学
凝结
瑞斯托西汀
内科学
止血
分裂细胞
胃肠病学
脾脏
抗凝血酶
血管性血友病因子
免疫学
内分泌学
血栓性血小板减少性紫癜
肝素
作者
S Visudhiphan,Kanchana Ketsa‐ard,A Piankijagum,S Tumliang
出处
期刊:PubMed
日期:1985-01-01
卷期号:39 (6): 264-71
被引量:20
摘要
To clarify the possible role of persistent thrombocytosis after splenectomy being a predisposing factor causing development of thromboembolism, blood coagulation profiles and platelet functions were studied in 34 cases being 1-18 years post-splenectomy from non-malignant diseases. Persistent thrombocytosis was observed in 16 with significant negative correlation between hemoglobin level and platelet count indicated the role of anemia on persistent post-splenectomy thrombocytosis. Blood coagulation profiles showed accelerated thrombin formation or hypercoagulability as measured by thrombin generation test especially in cases with thrombocytosis, together with decreased fibrinolytic activity and high fibrinogen, but in presence of high antithrombin III activity. Concerning the platelet, the aggregation to ristocetin was defective, the improved aggregation to ADP and adrenaline was achieved only in whom with intact spleen giving defective platelet aggregation. The finding indicated the role of spleen contributing to abnormal platelet aggregation. Another interesting observation was the decreased platelet 5-hydroxytryptamine content in splenectomized cases. The overall changes on blood coagulation and platelets post-splenectomy including those with persistent thrombocytosis did not thoroughly shift to hypercoagulable state, since a high antithrombin III activity and some platelet defect remained. These present findings, therefore, unlikely predisposed to the occurrence of thromboembolism even in those with persistent thrombocytosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI